Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways

Authors:
  • TOTakaya Ohno
    Takaya Ohno
  • YNYuki Nakajima
    Yuki Nakajima
  • YYYuki Yoshikawa
    Yuki Yoshikawa
  • TTTakuya Tsujino
    Takuya Tsujino
  • RMRyoichi Maenosono
    Ryoichi Maenosono
  • KNKo Nakamura
    Ko Nakamura
  • TTTomoaki Takai
    Tomoaki Takai
  • TUTaizo Uchimoto
    Taizo Uchimoto
  • TFTatsuo Fukushima
    Tatsuo Fukushima
  • KNKazuki Nishimura
    Kazuki Nishimura
  • YYYusuke Yano
    Yusuke Yano
  • THTakuya Higashio
    Takuya Higashio

Abstract
Introduction: Bladder cancer (BC) is influenced by hypoxic conditions, which promote tumor progression and resistance to therapy. MicroRNAs (miRNAs) play key roles in regulating gene expression under hypoxia. Methods: This study utilized an miRNA array to compare expression profiles under normoxic and hypoxic conditions. We analyzed 1,024 miRNAs, focusing on differentially expressed miRNAs. Survival analysis was performed using a cohort of 408 BC patients from TCGA (The Cancer Genome Atlas). Target prediction for hypoxia-inducible factors (HIFs) and cancer-related genes was performed. Results: Of 1,024 miRNAs, 508 were downregulated and 516 upregulated in hypoxia. Four miRNAs (hsa-miR-210, hsa-miR-4435, hsa-miR-6875, hsa-miR-193b) were upregulated >50-fold, and four (hsa-miR-1250, hsa-miR-1288, hsa-miR-362, hsa-miR-6828) were downregulated. Upregulated miRNAs were associated with a trend toward improved overall survival in 408 BC patients (log-rank p = 0.049). Three downregulated miRNAs targeted HIF-1α, while three upregulated miRNAs targeted HIF-3α. Hsa-miR-210 targeted AGO2 and USP10, with hsa-miR-4435 also targeting AGO2. Conclusion: BC under hypoxia exhibits a specific miRNA profile targeting HIFs and cancer-related genes including AGO2 and USP10, potentially influencing treatment success and survival.

This publication has 28 references indexed in Scilit: